We develop, manufacture, and deliver medical countermeasures that address public health threats.
ANTHRASIL®
[Anthrax Immune Globulin Intravenous (Human)]
BAT®
[Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)]
BioThrax®
(Anthrax Vaccine Adsorbed)
- US Prescribing Information
- Information Summary of Product Characteristics (Common – English version; Approved in DE, IT, FR, NL, PL, UK/NI)
- Information Package Information Leaflet (Common – English version; Approved in DE, IT, FR, NL, PL, UK/NI)
- Canadian Product Monograph (English)
- Canadian Product Monograph (French)
CYFENDUS®
(Anthrax Vaccine Adsorbed, Adjuvanted)
Ebanga™*
(ansuvimab-zykl)
raxibacumab injection
A fully human monoclonal antibody
RSDL®
(Reactive Skin Decontamination Lotion Kit)
Trobigard® Auto-injector**
(atropine sulfate, obidoxime chloride auto-injector)
VIGIV®
[Vaccinia Immune Globulin Intravenous (Human)]
*EbangaTM is a trademark of RIDGEBACK BIOTHERAPEUTICS L.P.
**The Trobigard Auto-injector is approved by the Federal Agency for Medicines and Health Products of Belgium. It is not approved by the U.S. Food and Drug Administration or the health regulatory authority of any other jurisdiction.